# A new ADHD drug targets three brain chemicals instead of two. Here’s what that means

> **Open Intelligence Dossier** · First detected: 2026-08-13 14:07 UTC · Category: Health

## Executive Summary
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"A new ADHD drug targets three brain chemicals instead of two. Here’s what that means" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Patient Care Online, FirstWord Pharma, Psychology Today and Physician's Weekly. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Patient Care Online | Centanafadine Gains FDA Approval for ADHD Across Age Groups | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxQS0piNU11MTczaDNPaXRlOUwwX19sek43dFg3cndUeUczQldjNDAxbTczRXpTREw3VXgzdWlWNXRjVDFNVm9uOWo3bkhuNnpZem41ZWNXVFpJYUN5UFdNbUd3RjFoWndPa3ZnMmVoSWNsTG9kSHR0MElEdjJxcmhnZVc5akpBVWdna2ktdWIwRnJwZ3VDZlpjVkszMkpuTmM?oc=5) |
| FirstWord Pharma | Physician Views Results: Simtriyo draws interest despite Schedule II wildcard | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE5tN2h3TWRSM1ZEWlpvcjN1UmttQTd3T21qOERFcFlNaTJiLUswS1JfVUl0MnlIbW5raHNmX1RtQnlQQ21XVmI1cXJIT2dJOW11ZGVN?oc=5) |
| Psychology Today | A new med is called a non-stimulant. The label says stimulant. The trials say less. | [Source Link](https://news.google.com/rss/articles/CBMizgFBVV95cUxONG9HSWpzY2EwbmZZbGFqVWVWQWJDY0J6azltMXF1REliTkxUSGlSLXBlWFlCbXRJd3ZNaXlESDJ0aGdfYVZieWZjMmg5cjdDc2txWGhRTzJFZjE4aG0zajJ3ckZreDczMVU3MkRpcXFFRUxqU0V4QjFoaEtzbjJHcUdIRmxYN1E3djFKSXJJWk1fYlRFSEtCMDBZS0NjZUtsZW9jNjFsbG9rSkE5ZTk5VkpCdnBESkxvM2pCaXJna0hIc1ptWWtobFhRY0Nmd9IB0wFBVV95cUxQUjhsRHA3MjQ4TEktdmRheDh4clhobEdSbml6eG9aM3NOdE05NXdPOTNoSUN5dy1YWmJtWHpiMUgyeWJLbEFMWWhMLUY0NzdHbm5LV0x0YnFjLVJJcEpaWmp2N0JzNnV2WFROdF9nSW5mMXJyWFZyY2RMbGdLN0RpZFpvUU5) |
| Physician's Weekly | FDA Approves Centanafadine for ADHD | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxPYnVnRmI1OVFiSjZEZHdETUExTUhWWFQwWldHaVFtQlUtN1Y2em0tQ3dsV0JnNVJvekt4SWdxaC1Pd3JrTTEyMXRxaXFWMG9WQ29uNk5zbVJqUnl6cFZXeXlpZHVPWm5zYUQ5bGtQR3YwLTZHVEEwaWthLUdGbnRGRWYwbVhXUVVCZmxtRlZB?oc=5) |
| The Conversation | A new ADHD drug targets three brain chemicals instead of two. Here’s what that means | [Source Link](https://news.google.com/rss/articles/CBMiuAFBVV95cUxNdmI2QVNIeHZ0M21lVHptU3lsT3ZFVDktaTh0VGt6SjhoZ3BWYnJYUDR1dlhmdy01RGtDS1E1VXhERjFuNmtMVjk0NFJjbzhJMXVMdzVLM2Y1dk11ckhVclFoWUxENDhaWThJNFNZYzFycHJnNzZfOGpDZTd4R01tbDl1cFhTczVQNFh1U0lRaXdxUF9XS3Vxay1qeDZfUHNYNzA3R3hFRjdRSmxxdGxMWTRqOFBEN0Rv?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-13/a-new-adhd-drug-targets-three-brain-chemicals-instead-of-two-here-s-what-that*